MedTrace Logo

The Effects of Miminal Stimulation Protocol on Preimplantation Genetic Screening

NCT05220995 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-02-02

No results posted yet for this study

Summary

PGS has been the most effective method for embryo selection in IVF cycles. Euploidy rates decrease significantly with advancing maternal age (AMA). The dosage of gonadotropins also may be increased to recruit an adequate number of follicles in AMA women, minimal Stimulation Protocol (MSP) with the new combination of human menopausal gonadotrophin (hMG) and clomiphene citrate (CC) for controlled ovarian hyperstimulation is defined for poor ovarian response women. The aim of this study is to show minimal stimulation protocol affect euploidy and pregnancy rates in preimplatation genetic screening (PGS) cycles with single embryo transfer.

Conditions

  • Preimplantation Genetic Screening

Interventions

GENETIC

protocol

ovarian stimulation protocols on euploid rates were compared.

Sponsors & Collaborators

  • Gokalp Oner

    lead OTHER

Eligibility

Min Age
38 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2022-01-23
Completion
2022-01-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05220995 on ClinicalTrials.gov